Therapeutic Solutions International
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Therapeutic Solutions International generated cash of -$1,055,290, which is less than the previous year. Cash used in financing activities reached the amount of $1,077,676 last year. Net change in cash is therefore -$1,614.
Cash Flow
| 2014 | -59.61K | 55K | -5K |
|---|---|---|---|
| 2015 | -372.05K | 0 | 371.34K |
| 2016 | -385.74K | 0 | 405.46K |
| 2017 | -366.71K | 0 | 344.83K |
| 2018 | -469.17K | 0 | 491.54K |
| 2019 | -310.71K | 0 | 314.74K |
| 2020 | -663.07K | -5.44K | 894.27K |
| 2021 | -718.92K | -256.55K | 817.38K |
| 2022 | -1.01M | 0 | 943.08K |
| 2023 | -1.05M | -24K | 1.07M |
TSOI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 29.43K | 104.25K | 262.34K | 36.59K | 32.57K | 10.20K | 21.91K | 2.18K | 2.89K | 12.51K |
Operating activities | ||||||||||
Net income | -2.16M | -3.67M | -2.96M | -2.19M | -1.69M | -1.86M | -995.47K | -1.06M | -586.44K | -288.75K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 311.77K | 244.63K | 18.06K | 6.98K | 6.59K | 194.98K | 27.45K | 0 | 0 | 21.13K |
Stock-based compensation expense | 395.54K | 1.64M | 1.33M | 1.16M | 468K | 0 | 144.95K | 288.3K | 286.2K | 45.75K |
| Deferred income tax benefit | 395.54K | 1.64M | 1.33M | 1.16M | 468K | 0 | 144.95K | 288.3K | 286.2K | 45.75K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 6.20K | -8.78K | -14.17K | 463 | -2.90K | 204.36K | 310.72K | 2.18K | -2.18K | 0 |
Inventories | 19.85K | -2.61K | -34.41K | -219 | -5.18K | 1.51K | 34.92K | -6.75K | -29.67K | 0 |
Accounts payable | -4.32K | 5.37K | 94.13K | -27.96K | 8.85K | -15.01K | 16.21K | 50.25K | -13.21K | -7.96K |
Cash generated by operating activities | -1.05M | -1.01M | -718.92K | -663.07K | -310.71K | -469.17K | -366.71K | -385.74K | -372.05K | -59.61K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -16.15K | 0 | -260.56K | -5.44K | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -24K | 0 | -256.55K | -5.44K | 0 | 0 | 0 | 0 | 0 | 55K |
Financing activities | ||||||||||
Common Stock Issued | 790.43K | 445K | 285.49K | 588.04K | 76.43K | 249K | 191K | 332K | 202.5K | 210K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 287.24K | -4.45K | -6.86K | -25.24K | 0 | -2.46K | 153.83K | -2.53K | 168.84K | -5K |
Cash used in financing activities | 1.07M | 943.08K | 817.38K | 894.27K | 314.74K | 491.54K | 344.83K | 405.46K | 371.34K | -5K |
Net Change In Cash | -1.61K | -75.21K | -158.09K | 225.75K | 4.02K | 22.36K | -21.88K | 19.72K | -711 | -9.61K |
Cash at end of period | 27.82K | 29.04K | 104.25K | 262.34K | 36.59K | 32.57K | 29 | 21.91K | 2.18K | 2.89K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |